Volastra Therapeutics Announces First Patient Dosed in Phase I/II Clinical Trial of VLS-1488, One in a Portfolio of Novel and Differentiated KIF18A Inhibitors
NEW YORK--(BUSINESS WIRE)--Oct 30, 2023--
Source: eagletribune.com
Danielle Cantey News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Danielle Cantey. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Danielle Cantey Today - Breaking & Trending Today
Altimmune to Participate at Two Upcoming Investor
GAITHERSBURG, Md., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that...
Source: globenewswire.com
Sonoma Biotherapeutics to Present Preclinical Data from Novel Treg Cell Therapy at Symposium on Hidradenitis Suppurativa Advances
SOUTH SAN FRANCISCO, Calif. & SEATTLE--(BUSINESS WIRE)--Oct 13, 2023--
Source: eagletribune.com
Zentalis Announces Presentation of Positive Phase 1b Data
Strong anti-tumor activity shown in a platinum-resistant ovarian cancer population, with a confirmed ORR of 50.0% and mPFS of 7.4 months in combination...
Source: globenewswire.com
Affini-T Therapeutics to Present AFNT-211 T Cell Product Attributes Targeting KRAS G12V at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
BOSTON & SEATTLE--(BUSINESS WIRE)--May 25, 2023--
Source: wsiltv.com